Not Signed In -
Cabergoline |
Dostinex |
Image:Cabergoline.png Cabergoline Systematic (IUPAC) name ? Identifiers CAS number 81409-90-7 ATC code G02CB03 N04BC06 PubChem 54746 DrugBank APRD00836 Chemical data Formula C26H37N5O2 Mol. weight 451.604 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Cabergoline (brand names Dostinex® and Cabaser®), an lys ...
Wikipedia - [full article]
Cabergoline Clinical Trials
- A study of Cabergoline for the Treatment of Cocaine Dependence - 1
ClinicalTrials.gov Identifier: NCT00033111 - Active, not recruiting
Cocaine-Related Disorders; Substance-Related Disorders
- Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
ClinicalTrials.gov Identifier: NCT00376064 - Recruiting
Acromegaly
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00153972 - Recruiting
Parkinson''s Disease
- Cabergoline Reduces OHSS
ClinicalTrials.gov Identifier: NCT00440258 - Completed
Ovarian Hyperstimulation Syndrome
- Cardiac Valve Complications in Prolactinomas Treated With Cabergoline
ClinicalTrials.gov Identifier: NCT00460616 - Completed
Prolactinomas
- A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00242008 - Completed
Parkinson's Disease
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects with Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00129181 - Completed
Parkinson Disease; Parkinsonian Syndrome
Resources
- Cabergoline (Drug Digest)
- Dostinex (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
